AI Generated Image
FDA Recalls Thyroid Meds Across the US
Newser • • business
Key Points:
- The FDA has issued a Class II recall for certain lots of levothyroxine sodium tablets from Major Pharmaceuticals due to the tablets being "subpotent" and potentially delivering less than the prescribed dose.
- Levothyroxine is commonly prescribed for underactive thyroid and goiter, and the FDA expects any health effects from the lower dose to be temporary and reversible.
- The recall affects specific 10-count blister packs and 100-tablet cartons ranging from 25 to 150 micrograms, with lot numbers and expiration dates from July 2026 to January 2027 listed on the FDA website.
- Patients are urged to check their medication against the FDA list and consult their healthcare provider before making any changes to their medication regimen.
